Alvarado, Maricel C.
HRN: 23-95-88 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/02/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/02/2025
05/09/2025
IV
4.5g
Q8h
T/C Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes